Researchers analyzed the effect of brimonidine in vitro, in vivo, and in a randomized exploratory trial and found that brimonidine reduces inflammation and erythema in rosacea by affecting the processes of neurogenic activation and neutrophil recruitment.

The investigators reported the rates of poor outcomes in patients with hrSCC treated with MMS alone, and explored specific clinical factors that may be more predictive of these outcomes.

The change from baseline in 2-hour pruritus score was shown to be statistically noninferior from IV cetirizine to IV diphenhydramine, in favor of IV cetirizine.

Patients with hereditary angioedema who received lanadelumab exhibited few cases of hypersensitivity and had low immunogenicity.

The prevalence of depression in patients with atopic dermatitis was higher than in those without atopic dermatitis.

The use of resiquimod gel 0.03%/0.01% is effective for the treatment of patients with actinic keratosis.

The members reached consensus on the use of a 5-point ordinal scale with descriptors provided via referenced electronic platforms.

Compared with baseline, significant reductions in noninflammatory, inflammatory, and total lesions were seen in the first 4 weeks of treatment with CL-BP 3.75%.

Study results suggest that vitiligo is associated with an increase in primary hospitalizations for several mental health conditions.

Generally, women with AD decreased dermatologic therapy during pregnancy.